The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Apr. 18, 2017
Applicants:

University of Maryland, College Park, College Park, MD (US);

The United States of America, As Represented BY the Secretary of the Navy, Washington, DC (US);

Inventors:

Christopher M. Jewell, Silver Spring, MD (US);

Krystina Hess, Rockville, MD (US);

Igor Medintz, Springfield, VA (US);

Kimihiro Susumu, Alexandria, VA (US);

Eunkeu Oh, Alexandria, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 39/39 (2006.01); B82Y 10/00 (2011.01); A61K 39/00 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61K 9/107 (2006.01); A61K 9/14 (2006.01); A61K 9/51 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6929 (2017.08); A61K 9/107 (2013.01); A61K 9/14 (2013.01); A61K 9/51 (2013.01); A61K 39/00 (2013.01); A61K 39/39 (2013.01); A61K 47/6923 (2017.08); A61P 25/00 (2018.01); A61P 25/28 (2018.01); B82Y 10/00 (2013.01);
Abstract

Provided are compositions and methods for promoting tolerance to auto-immune antigens. In general the compositions include quantum dots (QDs) that are in association with auto-immune peptide antigens. It is shown that QDs can be used to generate immunological tolerance by controlling the density of self-antigen on QDs. Peptide-QDs rapidly concentrate in draining lymph nodes, and co-localize with macrophages expressing scavenger receptors involved intolerance. Treatment with peptide-QDs reduces disease incidence 10-fold. The degree of tolerance and the underlying expansion of regulatory T cells correlates with the density of myelin molecules presented on QDs such that higher numbers of tolerogenic particles displaying lower levels of self-peptide are more effective for inducing tolerance than fewer particles each displaying higher densities of peptide. The disclosure is therefore relevant to promoting tolerance to antigens that are involved in a variety of autoimmune disorders.


Find Patent Forward Citations

Loading…